Effect of basic encephalitogenic protein and some peptides derived from it on the migration in agarose gel of leukocytes from patients with multiple sclerosis, other neurological diseases, or carcinoma.
D000690:Amyotrophic Lateral Sclerosis / Q000276:immunology; D000956:Antigens, Viral; D001921:Brain / Q000098:blood supply; D001932:Brain Neoplasms / Q000276:immunology; D002464:Cell Migration Inhibition; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000276:immunology; D005910:Glioma / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007238:Infarction / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008579:Meningioma / Q000276:immunology; D008722:Methods; D009103:Multiple Sclerosis / Q000276:immunology*; D004676:Myelin Basic Protein / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D011134:Polysaccharides
D000956:Antigens, Viral; D004676:Myelin Basic Protein; D010455:Peptides; D011134:Polysaccharides